RAFT: Beta Blocker Therapy in Congestive Heart Failure Patients With LVEF

03.09.20131785
Use of beta blocker therapy to treat congestive heart failure (CHF) patients with reduced left ventricular ejection fraction (LVEF) remains paramount, with benefits independent of those of newer CHF therapies, according to results of the RAFT Study presented on Sept. 2 during the ESC Congress 2013.

Randomized Trial of Preventive Angioplasty in Myocardial Infarction

02.09.20131820
In acute ST-segment elevation myocardial infarction (STEMI), the use of percutaneous coronary intervention (PCI) to treat the artery responsible for the infarct (infarct, or culprit, artery) improves prognosis.

Macitentan Cuts Morbidity, Death in Pulmonary Arterial HTN

30.08.20132015
For patients with pulmonary arterial hypertension, the new dual endothelin-receptor antagonist macitentan is associated with reductions in morbidity and mortality, according to a study published in the Aug. 29 issue of the New England Journal of Medicine.

ESC is pleased to endorse the 2nd Global Cardiovascular Forum in St. Petersburg in 2014

29.08.20132823
Professor Komajda is pleased to inform that Prs. Jeroen Bax and Alex Vahanian have accepted the endorsement by ESC of the 2nd Global Cardiovascular Forum in St. Petersburg in 2014.

Uric acid and risk of heart failure: a systematic review and meta-analysis

29.08.20131999
We aimed to perform a systematic review and meta-analysis to assess the association between serum uric acid and incident heart failure (HF)/prognosis of HF patients.

The 6-minute walking test and all-cause mortality in patients undergoing a post-cardiac surgery rehabilitation program

28.08.20131697
The 6-minute walking test (6mWT) is used to prescribe physical activity in cardiac surgery patients. The clinical value of a pre-discharge 6mWT and its association with outcome is not well defined.

Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure

27.08.20131791
We examined whether the severity of central sleep apnoea (CSA) and the level of C-reactive protein are associated with the prevalence and complexity of arrhythmias, and whether these factors contribute to increased risk of nocturnal sudden death.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.